Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Vedanta Biosciences

10 Disclosed Funding Rounds $243,594,519

0 Participating Investments


Business Development, Biotechnology, Medical

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Business Development,
Organizations in Cambridge in Biotechnology,
Organizations in Cambridge in Medical,
Organizations in Massachusetts in Business Development,
Organizations in Massachusetts in Biotechnology,
Organizations in Massachusetts in Medical,
Organizations in United States in Business Development,
Organizations in United States in Biotechnology,
Organizations in United States in Medical,
Organizations in North America in Business Development,
Organizations in North America in Biotechnology,
Organizations in North America in Medical

Investors in Cambridge in Business Development,
Investors in Cambridge in Biotechnology,
Investors in Cambridge in Medical,
Investors in Massachusetts in Business Development,
Investors in Massachusetts in Biotechnology,
Investors in Massachusetts in Medical,
Investors in United States in Business Development,
Investors in United States in Biotechnology,
Investors in United States in Medical,
Investors in North America in Business Development,
Investors in North America in Biotechnology,
Investors in North America in Medical

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2010

Founders David Steinberg, Dan Littman, Ruslan Medzhitov, Alexander Rudensky

Operating Status Active

Funding Stage Late Stage Venture

Last Funding Type Venture - Series Unknown

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Date Round Raised Lead
January, 12, 2021 Venture - Series Unknown $25,000,000 Pfizer Breakthrough Growth Initiative
September, 30, 2020 Grant $76,900,000 Biomedical Advanced Research and Development Authority (BARDA)
December, 05, 2019 Grant $5,800,000 CARB-X
September, 23, 2019 Series C $16,600,000 -------
May, 13, 2019 Series C $18,500,000 -------
December, 24, 2018 Series C $27,000,000 -------
July, 10, 2018 Grant Undisclosed Crohn's & Colitis Foundation of America
November, 03, 2017 Grant $5,400,000 CARB-X
June, 06, 2016 Venture - Series Unknown $50,000,000 Rock Springs Capital
June, 27, 2013 Venture - Series Unknown Undisclosed -------

Vedanta Biosciences Investors (26)

Investor Lead? Round Participating Raise Date Partners
Pfizer Breakthrough Growth Initiative Yes Venture - Series Unknown $25,000,000 January, 12, 2021 -------
Biomedical Advanced Research and Development Authority (BARDA) Yes Grant $76,900,000 September, 30, 2020 -------
CARB-X Yes Grant $5,800,000 December, 05, 2019 -------
Partners Investment No Series C $16,600,000 September, 23, 2019 -------
FC Capital No Series C $16,600,000 September, 23, 2019 -------
Symbiosis No Series C $16,600,000 September, 23, 2019 -------
QUAD Investment Management No Series C $16,600,000 September, 23, 2019 -------
Shinhan Private Equity No Series C $16,600,000 September, 23, 2019 -------
SV Investment Corp No Series C $16,600,000 September, 23, 2019 -------
Shinhan Capital No Series C $16,600,000 September, 23, 2019 -------
Shumway Capital No Series C $18,500,000 May, 13, 2019 -------
Partners Investment No Series C $18,500,000 May, 13, 2019 -------
JSR Corp No Series C $18,500,000 May, 13, 2019 -------
Symbiosis Group No Series C $18,500,000 May, 13, 2019 -------
Seventure Partners No Series C $27,000,000 December, 24, 2018 -------
Rock Springs Capital No Series C $27,000,000 December, 24, 2018 -------
Bristol-Myers Squibb No Series C $27,000,000 December, 24, 2018 -------
Invesco Asset Management No Series C $27,000,000 December, 24, 2018 -------
PureTech Health No Series C $27,000,000 December, 24, 2018 -------
Bill & Melinda Gates Foundation No Series C $27,000,000 December, 24, 2018 -------
Crohn's & Colitis Foundation of America Yes Grant Undisclosed July, 10, 2018 -------
CARB-X Yes Grant $5,400,000 November, 03, 2017 -------
Invesco No Venture - Series Unknown $50,000,000 June, 06, 2016 -------
PureTech Health No Venture - Series Unknown $50,000,000 June, 06, 2016 -------
Rock Springs Capital Yes Venture - Series Unknown $50,000,000 June, 06, 2016 -------
Johnson & Johnson Development Corporation No Venture - Series Unknown Undisclosed June, 27, 2013 -------